CARL

$15.02+0.47%visit website

CARLSMED, INC.

Market Cap

$410M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

—

Insufficient price history

P/E (TTM)

N/M

TTM to Jun 2026 · negative earnings

P/S (TTM)

6.5

TTM to Jun 2026 · revenue

P/B

4.9

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

N/M

TTM to Jun 2026 · negative EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	13,074	15,165	16,116	18,940	63,295
Cost of revenue	3,147	3,557	3,691	4,398	14,793
Gross profit	9,927	11,608	12,425	14,542	48,502
Research & development	4,445	5,264	5,178	6,040	20,927
Total operating expenses	18,962	20,926	21,701	25,578	87,167
Operating income	(9,035)	(9,318)	(9,276)	(11,036)	(38,665)
Interest expense	380	330	311	313	1,334
Income tax	0.00	0.00	0.00	0.00	0.00
Net income	(8,526)	(8,613)	(8,696)	(10,510)	(36,345)
EPS (basic) ($)	(0.40)		(0.32)	(0.39)	—
EPS (diluted) ($)	(0.40)		(0.32)	(0.39)	—
Weighted avg. shares (basic)	21,081		26,836	27,191
Weighted avg. shares (diluted)	21,081		26,836	27,191

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 5, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 5 more quarters, back to Jun 2024, with Tormere Pro.

Signals

purchases / sales, 90d

Short Volume

67%

W/W -23.9pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

0.04x

Avg Daily Selling (90d)

13.7 sh/day

Baseline Daily Selling

808 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-10-30	2026-11-02	Bertolini Jeffrey	Chief Operating Officer	Sale	243	$15.80	$4K	22.5K	View
2026-10-05	2026-10-06	Bertolini Jeffrey	Chief Operating Officer	Sale	747	$14.39	$11K	22.5K	View
2026-09-30	2026-10-01	Bertolini Jeffrey	Chief Operating Officer	Sale	243	$13.99	$3K	22.5K	View
2026-03-02	2026-03-04	Cordonnier Michael	Director & CEO, President	Sale	197.9K	$13.29	$2.63M	1.36M	View

Reporting Insiders

Recent News

Carlsmed (Nasdaq:CARL) - Stock Analysis

Simply Wall St · 2026-10-29

Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026

Yahoo · 2026-10-27

Carl Zeiss Meditec AG (CZMWY) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2026-10-27

Carl Zeiss Meditec: Why The Market Is Finally Recognizing The Recovery

Seeking Alpha · 2026-10-27

Cloudflare director Carl Ledbetter sells $1.52m in stock

Investing.com · 2026-10-19

Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System

Yahoo · 2026-10-14

BTIG Maintains Buy on Carlsmed, Raises Price Target to $24

Benzinga · 2026-10-12

Carlsmed, Inc. (NASDAQ:CARL) Stock Has Consensus Target Price of $19.25

MarketBeat · 2026-10-10

Why is Carl Zeiss Meditec stock sliding today?

Investing.com · 2026-10-05

Carlsmed, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Yahoo Finance · 2026-10-02

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

Yahoo Finance · 2026-10-01

Carlsmed names new CFO

Yahoo Finance · 2026-09-29

Carlsmed Appoints Richard Heppenstall as Chief Financial Officer

Yahoo Finance · 2026-09-28

Carl Zeiss Meditec (XTRA:AFX) Stock Could Be Undervalued After An 81% Fall

Yahoo Finance · 2026-09-23

Silver Lake sues Carl Icahn and hedge funds over Endeavor buyout

Yahoo Finance · 2026-09-21

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-10-30	Bertolini Jeffrey	S	243	$3,839.4
2026-10-05	Bertolini Jeffrey	S	747	$10,749.33
2026-09-30	Bertolini Jeffrey	S	243	$3,399.57
2026-03-02	Cordonnier Michael	S	197,855	$3M

CARL

Financial Statements

Signals

Factor Profile

Reporting Insiders

Recent News

CARLSMED, INC. (CARL)

Factor Profile